ArticleChemico-biological interactions2021

Low risk of the TMPRSS2 inhibitor camostat mesylate and its metabolite GBPA to act as perpetrators of drug-drug interactions.

Johanna Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.